Fundación Puigvert, Barcelona Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2008
NCT00634621
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Fundación Puigvert, Barcelona. Spain